Neurogene director files amended Form 3

Neurogene Inc. director Woods Keith filed an amended Form 3, which is the initial statement of beneficial ownership for insiders.

Accepted by SEC EDGAR 06/16/2026 - 05:30 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Neurogene Inc. director Woods Keith filed an amended Form 3, which is the initial statement of beneficial ownership for insiders. This amendment reports no share purchases, sales, option exercises, or other equity transactions, and shows no derivative securities or other holdings disclosed in this filing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Neurogene (NGNE) disclose in this amended Form 3 for Woods Keith?

The amended Form 3 for Neurogene director Woods Keith reports his beneficial ownership status as an insider. It shows no reported common stock or derivative security transactions and no listed holdings in this particular amendment, serving mainly as an updated ownership disclosure record.

Does the Neurogene (NGNE) Form 3/A show any insider buying or selling?

No, the Neurogene Form 3/A for Woods Keith reports zero insider purchases, sales, gifts, exercises, or other equity transactions. All transaction-related counts and share amounts in the summary are listed as zero, indicating no trading activity covered by this amendment.

Who is the reporting person in this Neurogene (NGNE) Form 3/A filing?

The reporting person is Woods Keith, identified as a director of Neurogene Inc. The filing confirms his status as a board member and provides an amended initial beneficial ownership statement, even though it does not list specific share or option holdings in this amendment.

Are any derivative securities reported in Neurogene (NGNE) director Woods Keith’s Form 3/A?

No derivative securities are reported in this Form 3/A. The derivative summary shows no entries, meaning there are no options, warrants, or other derivative positions disclosed for Woods Keith in this particular amended filing with Neurogene.

Does the Neurogene (NGNE) Form 3/A indicate any net change in insider position?

The Form 3/A indicates no net change in position. Net buy/sell shares are reported as zero and the net direction is neutral, confirming that the amendment records no new insider transactions affecting Woods Keith’s ownership during the period covered.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Woods Keith

(Last) (First) (Middle)

C/O NEUROGENE INC.

535 W 24TH ST, 5TH FLOOR

(Street)

NEW YORK NEW YORK 10011

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/18/2023

3. Issuer Name and Ticker or Trading Symbol
Neurogene Inc. [ NGNE ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)
12/26/2023

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

This Form 3 was originally filed on December 26, 2023 using the incorrect CIK number for the Reporting Person and is being refiled under the correct CIK number. This filing amends and replaces the original filing in its entirety.

No securities are beneficially owned.

	/s/ Donna M. Cochener, Attorney-in-Fact for Keith Woods	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)